Search for Clinical Trial Results

Sponsored By

Polycythemia Vera - 27 Studies Found

Status Study
Completed Study Name: Dasatinib in Polycythemia Vera
Condition: Polycythemia Vera
Date: 2007-10-02
Interventions: Drug: Dasatinib Patients will receive a once-daily oral administration of dasatinib at a dose of 100 mg
Terminated Study Name: A Phase 1 Study of XL019 in Adults With Polycythemia Vera
Condition: Polycythemia Vera
Date: 2008-01-07
Interventions: Drug: XL019 XL019 capsules administered orally
Completed Study Name: Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Condition: Polycythemia Vera
Date: 2012-06-29
Interventions:
  • Drug: Ruxolitinib Ruxolitinib

Completed Study Name: Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera
Condition: Polycythemia Vera
Date: 2005-10-17
Interventions: Drug: pegylated interferon-alfa 2a
Completed Study Name: Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera
Condition: Polycythemia Vera
Date: 2009-06-25
Interventions:
  • Drug: GIVINOSTAT (ITF2357) 50 mg o.d. + MTD Hydroxyurea

Not yet recruiting Study Name: Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features
Condition: Polycythemia Vera
Date: 2016-06-18
Interventions: Other: questionnaires • Influence of iron parameters on Patient-reported symptoms as assessed by M
Recruiting Study Name: A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera
Condition: Polycythemia Vera
Date: 2013-07-10
Interventions: Drug: Givinostat In Part A patients will treated in dose l
Completed Study Name: Treatment of Polycythemia Vera With Gleevec
Condition: Polycythemia Vera
Date: 2010-05-07
Interventions: Drug: Gleevec 400 mg once daily for 12 months Other
Recruiting Study Name: Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Are Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Are Available.
Condition: Polycythemia Vera
Date: 2014-11-05
Interventions: Drug: Ruxolitinib
Active, not recruiting Study Name: Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)
Condition: Polycythemia Vera
Date: 2014-09-23
Next >>>